CClinicalTrials.gg
CompletedNCT00005731Updated Jun 24, 2005

Develop and Implement Asthma Controlling Strategies

An observational study in Asthma and Lung Diseases, sponsored by National Heart, Lung, and Blood Institute (NHLBI). Completed. Open to male participants aged 0 Years and older. Per ClinicalTrials.gov, last updated 2005-06-24.

Sponsored by National Heart, Lung, and Blood Institute (NHLBI) · Observational

Study type
Observational
Model
Natural history
Ages
0 Years and older
Sex
Male
01

Study summary

To develop and implement asthma-controlling educational strategies for inner city and high risk populations.

Read the detailed description

BACKGROUND:

Asthma is a serious chronic disease affecting about 12 million Americans; about 3 million are children. The study was part of an initiative, "Developing and Implementing at the State and Local Level Educational Strategies and Interventions for Controlling Asthma in Inner City and High Risk Populations", released in February 1993 by the National Asthma Education Program of the Office of Prevention, Education and Control.

DESIGN NARRATIVE:

A computer-assisted multimedia instructional and feedback system, "Asthma Patient/Provider Partnership System" (APPPS), was developed for African American and Hispanic school-age children that was suited for adoption and implementation in clinical and other settings based on the National Asthma Education Program's Expert Panel Guidelines on the Diagnosis and Management of Asthma. A formative evaluation of the educational intervention was conducted. Also, an efficacy study of the intervention in three clinical settings was conducted and the findings of this study were incorporated into the APPPS. Finally, a recommended dissemination strategy was prepared for diffusion of the system to other settings.

02

Conditions studied

  • Asthma
  • Lung Diseases
03

In context

Asthma

3,921 studies on the registry are indexed under Asthma; 507 are open to participants now.

Browse Asthma studies →

Lead sponsor

National Heart, Lung, and Blood Institute (NHLBI) is the lead sponsor of 1,117 studies on the registry; 71 are open to participants now.

Of its 57 completed or terminated interventional studies of FDA-regulated products, 49 (86%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
0 Years and older
Sexes eligible
Male
Accepts healthy volunteers
No

Eligibility criteria

No eligibility criteria

05

Study design

Observational model
Natural history
06

Study locations

No study locations are listed for this record.

07

References and documents

Publications

  • Bartholomew LK, Gold RS, Parcel GS, Czyzewski DI, Sockrider MM, Fernandez M, Shegog R, Swank P. Watch, Discover, Think, and Act: evaluation of computer-assisted instruction to improve asthma self-management in inner-city children. Patient Educ Couns. 2000 Feb;39(2-3):269-80. doi: 10.1016/s0738-3991(99)00046-4. PubMed 11040726 ↗
  • Bartholomew LK, Shegog R, Parcel GS, Gold RS, Fernandez M, Czyzewski DI, Sockrider MM, Berlin N. Watch, Discover, Think, and Act: a model for patient education program development. Patient Educ Couns. 2000 Feb;39(2-3):253-68. doi: 10.1016/s0738-3991(99)00045-2. PubMed 11040725 ↗
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 24, 2005, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00005731
Lead sponsor
National Heart, Lung, and Blood Institute (NHLBI)
First posted
May 26, 2000
Start date
Sep 1993
Completion
May 1997
Last update
Jun 24, 2005
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2001. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion